Who is Who in Clinical Diagnostics in India (Markets, Distributors, Companies, Countr Overview)

Abstract

This country of 1.3 billion people is now America' s sixth largest export market, and India' s economy, while showing some effects of the world recession, has been less impacted than other nations and is showing growth, although not as rapid as in recent years. Who is Who in Clinical Diagnostics in India, produced jointly with the firm McEvoy & Farmer, is the product of on-the-ground primary research on Indian labs conducted in fall and winter 2008. Included in this report:

• Market Size Estimate by Major Category (Chemistry, Critical Care Chemistry, Urine Chemistry, Hematology, Flow Cytometry, Coagulation, Immunochemistry, Molecular Testing, Other IVD)
• Country Industry Overview
• Indian Hospital Statistics
• Profiles of 42 International Diagnostic Companies with operations in India
• Profiles of 130 Domestic Diagnostic Companies
• Profiles of 24 Local Distributors, indicating the companies they distribute for

The Indian market represents a significant opportunity for IVD diagnostic companies. But actionable information about this emerging market is often difficult to get. Only with an exhaustive, on-the-ground research team can a company truly understand the chinese market. Now, a resource is available that can make on-the-ground research available to all companies at a fraction of the cost.

Published jointly with trusted Asian IVD market experts McEvoy and Farmer, this Kalorama report is a complete survey of the IVD market in India today. Market size for major categories of the IVD market, products on the market, important Indian market trends and intense company profiles are part of this exhaustive study.

A number of recent events and trends in the Chinese healthcare environment are making China an increasingly attractive market opportunity for in vitro diagnostics companies. The increasing numbers of private laboratories and expanded reference laboratories are expanding the market for tests of all kinds.

Although there are a number of challenges for diagnostic manufacturers to understand and overcome, the market for clinical diagnostics in China (both reagents and instruments) remains one of the most promising emerging markets in the world.